What is sufficient evidence for the reliability and validity of patient-reported outcome measures?

被引:352
|
作者
Frost, Marlene H.
Reeve, Bryce B.
Liepa, Astra M.
Stauffer, Joseph W.
Hays, Ron D.
Sloan, Jeff A.
机构
[1] Mayo Clin, Womens Canc Program, Rochester, MN USA
[2] NCI, Div Canc Control & Populat Sci, Outcomes Res Branch, Appl Res Program, Bethesda, MD 20892 USA
[3] Eli Lilly & Co, Global Hlth Outcomes, Indianapolis, IN 46285 USA
[4] Alpharma, Global Med Affairs, Piscataway, NJ USA
[5] Univ Calif Los Angeles, Dept Hlth Sci, Dept Med, UCLA Div Gen Internal Med & Hlth Ser Res, Los Angeles, CA USA
[6] RAND Corp, Santa Monica, CA USA
关键词
patient-reported outcomes; psychometric; validation;
D O I
10.1111/j.1524-4733.2007.00272.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
This article focuses on the necessary psychometric properties of a patient-reported outcomes (PROs) measure. Topics include the importance of reliability and validity, psychometric approaches used to provide reliability and validity estimates, the kinds of evidence needed to indicate that a PRO has a sufficient level of reliability and validity, contexts that may affect psychometric properties, methods available to evaluate PRO instruments when the context varies, and types of reliability and validity testing that are appropriate during different phases of clinical trials. Points discussed include the perspective that the psychometric properties of reliability and validity are on a continuum in which the more evidence one has, the greater confidence there is in the value of the PRO data. Construct validity is the type of validity most frequently used with PRO instruments as few "gold standards" exist to allow the use of criterion validity and content validity by itself only provides beginning evidence of validity. Several guidelines are recommended for establishing sufficient evidence of reliability and validity. For clinical trials, a minimum reliability threshold of 0.70 is recommended. Sample sizes for testing should include at least 200 cases and results should be replicated in at least one additional sample. At least one full report on the development of the instrument and one on the use of the instrument are deemed necessary to evaluate the PRO psychometric properties. Psychometric testing ideally occurs before the initiation of Phase III trials. When testing does not occur prior to a Phase III trial, considerable risk is posed in relation to the ability to substantiate the use of the PRO data. Various qualitative (e.g., focus groups, behavioral coding, cognitive interviews) and quantitative approaches (e.g., differential item functioning testing) are useful in evaluating the reliability and validity of PRO instruments.
引用
收藏
页码:S94 / S105
页数:12
相关论文
共 50 条
  • [1] Reliability and Validity of Patient-Reported Outcome Measures for Ankle Instability in Hebrew
    Gottlieb, Uri
    Yona, Tomer
    Lumbroso, David Shein
    Hoffman, Jay R.
    Springer, Shmuel
    MEDICAL SCIENCE MONITOR, 2022, 28
  • [2] RELIABILITY AND VALIDITY OF A NEW PATIENT-REPORTED OUTCOME FOR GASTROPARESIS
    Cheng, R.
    Barnes, C.
    Zhou, K.
    Morris, S.
    Goyal, A.
    Cole, J. C.
    VALUE IN HEALTH, 2018, 21 : S149 - S149
  • [3] Evaluation of Validity, Reliability, and Feasibility of 3 Patient-Reported Foot and Ankle Outcome Measures
    Venkatesan, Murali
    Aziz, Sheweidin
    Mahadevan, Dev
    Korim, Tawfiq
    Dias, Joe
    Bhatia, Maneesh
    JOURNAL OF FOOT & ANKLE SURGERY, 2020, 59 (03): : 507 - 512
  • [4] A systematic review of the validity and reliability of patient-reported experience measures
    Bull, Claudia
    Byrnes, Joshua
    Hettiarachchi, Ruvini
    Downes, Martin
    HEALTH SERVICES RESEARCH, 2019, 54 (05) : 1023 - 1035
  • [5] Content validity and legacy patient-reported outcome measures in cancer
    Smith, Adam B.
    Cocks, Kim
    QUALITY OF LIFE RESEARCH, 2015, 24 (07) : 1585 - 1586
  • [6] Content validity and legacy patient-reported outcome measures in cancer
    Adam B. Smith
    Kim Cocks
    Quality of Life Research, 2015, 24 : 1585 - 1586
  • [7] Patient-reported outcome measures
    Ribeiro, Bernard
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2007, 100 (09) : 397 - 397
  • [8] Validity and Reliability of Four Parent/Patient-Reported Outcome Measures for Juvenile Idiopathic Arthritis Remote Monitoring
    van Dijkhuizen, E. H. Pieter
    Ridella, Francesca
    Naddei, Roberta
    Trincianti, Chiara
    Avrusin, Ilia
    Mazzoni, Marta
    Sutera, Diana
    Ayaz, Nuray Aktay
    Penades, Inmaculada Calvo
    Constantin, Tamas
    Herlin, Troels
    Oliveira, Sheila K.
    Rygg, Marite
    Sanner, Helga
    Susic, Gordana
    Sztajnbok, Flavio
    Varbanova, Boriana
    Ruperto, Nicolino
    Ravelli, Angelo
    Consolaro, Alessandro
    ARTHRITIS CARE & RESEARCH, 2023, 75 (02) : 391 - 400
  • [9] Reliability and Validity of Upper Extremity Patient-Reported Outcome Measures in Assessing Traumatic Finger Amputation Management
    Yoon, Alfred P.
    Kaur, Surinder
    Chou, Ching-Han
    Chung, Kevin C.
    Malay, Sunitha
    Shauver, Melissa
    Wang, Lu
    Zhong, Lin
    Sommers, Katie
    Hume, Keith
    Sawada, Hideyoshi
    Hsu, Chung Chen
    Tsai Tai-Jung
    Yang, Guang
    Zhang, Zhan
    Giladi, Aviram
    Fleming, Ike
    Sabapathy, S. Raja
    Kumaran, M. Senthil
    Ishiko, Toshihiro
    Nishizuka, Takanobu
    Kawamura, Kenji
    Sebastin, Sandeep
    Yong, Jasmine
    Jain, Sonu
    Colvell, Kara
    Lacey, Martin
    Hillard, Christopher
    Fowler, Jason
    Neumeister, Michael
    Lovel, Breana
    Kao, Dennis
    Arif, Hikmatullah
    Spiess, Alexander
    Grybowski, Damian
    Michelotti, Brett
    Costa, Beth
    Drolet, Brian
    Bueno, Reuben A., Jr.
    Spear, Marcia
    Woo, Sang Hyun
    Kim, Young Woo
    Moore, Amy
    Bettlach, Carrie Roth
    Linkugel, Andrew
    Dalton, Jay
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2020, 145 (01) : 94E - 105E
  • [10] Patient-reported Outcome Measures - A Call for More Narrative Evidence
    Meadows, Keith
    JOURNAL OF PATIENT EXPERIENCE, 2021, 8